Dr. Siraj Husain completed medical school at the Dalhousie University (Halifax, Nova Scotia) followed by residency training at the University of Alberta (Edmonton, Alberta). He completed a fellowship in Radiation Oncology at the University of Western Ontario (London, Ontario). His current clinical areas of focus include genitourinary and breast cancer. He has clinical and research interests in Brachytherapy and leads the implementation and training of HDR to new physicians at the Tom Baker Cancer Centre (TBCC). Dr. Husain is the Clinical and Research Program Leader for Prostate Brachytherapy, Radiation Oncology, at the TBCC. Active areas of research include enhancement and progression of combined modality therapy (Prostate Brachy + External Beam Radiation Therapy), champion for intermediate and high risk prostate cancer “drafted protocol” for introduction of High Dose Rate (HDR) and research, and continuing to advocate for Breast Brachytherapy – with new research projects to enhance and improve the procedure.
Area of Focus
Summary of Research
Key Publications:
- Meyer T, Quirk S, Husain S, Hilts M, Crook J, Watt E, Guebert A, Frederick A, Batchelar D, Kry SF, Roumeliotis M. Peer-based credentialing for brachytherapy: Application in permanent seed implant. Brachytherapy. 2020 May 10:S1538-4721(20)30052-0. doi: 10.1016/j.brachy.2020.03.007. [Online ahead of print]
- Martell K, Roy S, Meyer T, Stosky J, Jiang W, Thind K, Roumeliotis M, Bosch J, Angyalfi S, Quon H, Husain S. Retrospective analysis of outcomes after non-contour-based dose painting of dominant intra-epithelial lesion in intra-operative low-dose rate brachytherapy. Heliyon. 2020. [In Press]
- Samson N, Quirk S, Husain S, Balogh A, Quon H, Skarsgard D, Martell K. Clinical Outcomes of High-Dose Palliative Radiotherapy for Elderly Patients with Prostate Cancer. International Journal of Radiation Oncology Biology Physics. 2020 [In press]
- Elangovan A, Husain S, McGeachy P, Roumeliotis M, Wu D, Wolfe N, Meyer T, Watt E, Martell K, Thind K. Implementation of high dose rate brachytherapy for prostatic carcinoma in an unshielded operating room facility. Submitted to “Brachytherapy” journal. [In review]
- Roumeliotis M, Quirk S, Husain S, Guebert A, Watt E, Frederick A, Martell K, Hilts M, Crook J, Batchelar D, Ma I, Meyer T. Establishing a simulation-based education program for radiation oncology learners in permanent seed implant brachytherapy: Building validation evidence. Brachytherapy. 2019 Nov 27. pii: S1538-4721(19)30619-1. doi: 10.1016/j.brachy.2019.11.001.
- Hallemeier CL, Zhang P, Pisansky TM, Hanks GE, McGowan DG, Roach M 3rd, Zeitzer KL, Firat SY, Husain SM, D’Souza DP, Souhami L, Parliament MB, Rosenthal SA, Lukka HR, Rotman M, Horwitz EM, Miles EF, Paulus R, Sandler HM. Prostate-Specific Antigen After Neoadjuvant Androgen Suppression in Prostate Cancer Patients Receiving Short-Term Androgen Suppression and External Beam Radiation Therapy: Pooled Analysis of Four NRG Oncology Radiation Therapy Oncology Group Randomized Clinical Trials. Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):1057-1065. doi: 10.1016/j.ijrobp.2019.03.049. Epub 2019 Apr 6.
- Watt E, Skarsgard M, Roumeliotis M, Husain S, Meyer T. Post-implant analysis in permanent breast seed implant: automated plan reconstruction using simulated annealing. J Contemp Brachytherapy. 2019 Feb;11(1):61-68. doi: 10.5114/jcb.2019.83338. Epub 2019 Feb 28.
Area Of Focus
Summary Of Research
Key Publications:
- Meyer T, Quirk S, Husain S, Hilts M, Crook J, Watt E, Guebert A, Frederick A, Batchelar D, Kry SF, Roumeliotis M. Peer-based credentialing for brachytherapy: Application in permanent seed implant. Brachytherapy. 2020 May 10:S1538-4721(20)30052-0. doi: 10.1016/j.brachy.2020.03.007. [Online ahead of print]
- Martell K, Roy S, Meyer T, Stosky J, Jiang W, Thind K, Roumeliotis M, Bosch J, Angyalfi S, Quon H, Husain S. Retrospective analysis of outcomes after non-contour-based dose painting of dominant intra-epithelial lesion in intra-operative low-dose rate brachytherapy. Heliyon. 2020. [In Press]
- Samson N, Quirk S, Husain S, Balogh A, Quon H, Skarsgard D, Martell K. Clinical Outcomes of High-Dose Palliative Radiotherapy for Elderly Patients with Prostate Cancer. International Journal of Radiation Oncology Biology Physics. 2020 [In press]
- Elangovan A, Husain S, McGeachy P, Roumeliotis M, Wu D, Wolfe N, Meyer T, Watt E, Martell K, Thind K. Implementation of high dose rate brachytherapy for prostatic carcinoma in an unshielded operating room facility. Submitted to “Brachytherapy” journal. [In review]
- Roumeliotis M, Quirk S, Husain S, Guebert A, Watt E, Frederick A, Martell K, Hilts M, Crook J, Batchelar D, Ma I, Meyer T. Establishing a simulation-based education program for radiation oncology learners in permanent seed implant brachytherapy: Building validation evidence. Brachytherapy. 2019 Nov 27. pii: S1538-4721(19)30619-1. doi: 10.1016/j.brachy.2019.11.001.
- Hallemeier CL, Zhang P, Pisansky TM, Hanks GE, McGowan DG, Roach M 3rd, Zeitzer KL, Firat SY, Husain SM, D’Souza DP, Souhami L, Parliament MB, Rosenthal SA, Lukka HR, Rotman M, Horwitz EM, Miles EF, Paulus R, Sandler HM. Prostate-Specific Antigen After Neoadjuvant Androgen Suppression in Prostate Cancer Patients Receiving Short-Term Androgen Suppression and External Beam Radiation Therapy: Pooled Analysis of Four NRG Oncology Radiation Therapy Oncology Group Randomized Clinical Trials. Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):1057-1065. doi: 10.1016/j.ijrobp.2019.03.049. Epub 2019 Apr 6.
- Watt E, Skarsgard M, Roumeliotis M, Husain S, Meyer T. Post-implant analysis in permanent breast seed implant: automated plan reconstruction using simulated annealing. J Contemp Brachytherapy. 2019 Feb;11(1):61-68. doi: 10.5114/jcb.2019.83338. Epub 2019 Feb 28.